CLASS I Drug recall · Reported 1 Jun 2016 · FDA Enforcement Report

0.9% Sodium Chloride Injection recalled by Baxter Healthcare

Baxter Healthcare is recalling 0.9% Sodium Chloride Injection USP, Mini-bag Plus Container Viaflex Single Dose Container, distributed nationwide in the US. The recall was initiated on 21 Jan 2016 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: P328997, Exp 01/31/2016
NDC0338-0553
Quantity recalled273,520 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0862-2016
FDA event ID
73118
Recalling firm
Baxter Healthcare, Deerfield, IL
Manufacturer
Baxter Healthcare Corporation
Classification
Class I
Status
Terminated
Recall initiated
21 Jan 2016
FDA classified
23 May 2016
Reported
1 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

21 Jan 2016Recall initiated by company
23 May 2016Classified by FDA+123 days
1 Jun 2016Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: identified as cardboard.

Product as listed by the FDA

0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: identified as cardboard.

Which lots are affected?

Lot #: P328997, Exp 01/31/2016

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 73118

This product is part of a recall event; the main page for the event is Metronidazole Injection USP, 500 mg recalled by Baxter Healthcare.

More recalls from Baxter Healthcare

All 571

Other Sodium Chloride recalls

All 132